NCT00596245View on ClinicalTrials.gov

Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Healthy
Interventions
DRUG

MT400

MT 400, naproxen sodium 550mg

Trial Locations (1)

78744

Matthew M. Medlock, MD, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline

Collaborators (1)

POZEN
All Listed Sponsors
collaborator

POZEN

INDUSTRY

lead

GlaxoSmithKline

INDUSTRY

NCT00596245 - Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets | Biotech Hunter | Biotech Hunter